A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

Название протокола
Клинические исследование Gastric Neoplasms: Zanidatamab, Tislelizumab, Trastuzumab, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil, In situ hybridization (ISH)-based companion diagnostic assay, Immunohistochemistry (IHC)-based companion diagnostic a
Платное
Нет
Дата начала и окончания КИ
2022-02-06 - 2022-02-06